Logo
x

Search

Subscribe Now

Fractyl Health

Fractyl Health Highlights the Preclinical Data of its Pancreatic Gene Therapy at DDW 2024

Fractyl Health Highlights the Preclinical Data of its Pancreatic Gene Therapy at DDW 2024

  • May 20, 2024
The US FDA Grants IDE Approval to Fractyl Health for Initiating Remain-1 Trial of Revita to Treat Obesity

The US FDA Grants IDE Approval to Fractyl Health for Initiating Remain-1 Trial of Revita to Treat Obesity

  • April 1, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.